Please assess the completion status of the following clinical trial:

Trial Title: Intranasal Dexmedetomidine for Sedated Hearing Testing

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Child aged 1 to 15 years old~* American Society Anesthesiologists (ASA) scale patient 1 or 2~* Need to evaluate the child audition in a context of suspicion of deafness, delay of language, global delay of the development, the risk factors of hearing loss~* Impossibility to realize a hearing test by conventional audiogram or behavioral due to a cognitive or behavioral disorder of the child~* Affiliation to social security scheme~* Signature of the authorization documents of the 2 parents or the representative of the parental authority for the participation of the child in the study~Exclusion Criteria:~* Heart disease or heart rhythm disorder~* Pneumopathy or asthmatic crisis in previous 2 weeks in the examination~* Recent used of digoxine or beta-blocker~* Use of anti-epileptic or psychotropic drugs~* Medical history of sleep apnea~* Receptor alpha2 agonist allergy~* Gastrooesophageal reflux disease~* Upper airway abnormality~* Acute cerebrovascular diseases~* Neurologic disorders ( cranial trauma and after neurosurgical operation)~* Recent cerebral vascular accident~* Moyamoya disease~* General anesthesia planned for another procedure

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 15 Years
- Healthy Volunteers: f

Study Arms:
- Dexmedetomidine Hydrochloride (Type: EXPERIMENTAL): sedation of patients to perform auditory test

Based on this trial design, predict the completion outcome and termination type (if applicable).